| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.034 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |